PC-05 assesses the rate of newborns exclusively fed breast milk during the newborn´s entire hospitalization. This measure is a part of a set of four nationally implemented measures that address perinatal care (PC-01: Elective Delivery, PC-02: Cesarean Section, ePC-02 Cesarean Birth will be added as an eCQM 1/1/2020, PC-06 Unexpected Complications in Term Newborns was added as a chart-based measure on 1/1/2019). ePC-05: Exclusive Breast Milk Feeding, is one of three measures in this set that has been reengineered as eCQMs and is included in the Hospital Inpatient Quality Reporting (IQR) Program and the Medicare and Medicaid Promoting Interoperability programs.
Increasing the number of newborns who are exclusively fed breast milk for the first six months of life remains a major goal of the WHO, DHHS, AAP and ACOG. Guidelines for the promotion of breast milk feeding are available from the CDC to assist hospitals in establishing successful interventions to improve exclusive breast milk feeding rates in newborns. Breast milk feeding results in numerous health benefits for both mother and newborn. Breastfeeding is associated with decreased risk for many early-life diseases and conditions, including otitis media, respiratory tract infections, atopic dermatitis, gastroenteritis, type 2 diabetes, sudden infant death syndrome, and obesity. Breastfeeding also is associated with health benefits to women, including decreased risk for type 2 diabetes, ovarian cancer, and breast cancer. The measure assists health care organizations (HCOs) to track evidence of increases in the number of newborns who were exclusively fed breast milk during the birth hospitalization.
-
-
1.5 Measure Type1.7 Electronic Clinical Quality Measure (eCQM)1.20 Testing Data Sources
-
1.14 Numerator
Inpatient hospitalization for newborns that were fed breast milk only since birth
-
1.15 Denominator
Inpatient hospitalization for single newborns with an estimated gestational age at birth of >=37 weeks who are born in the hospital and who did not have a diagnosis of galactosemia, were not subject to parenteral nutrition, and had a length of stay of less than or equal to 120 days that ends during the measurement period.
-
Exclusions
- Inpatient hospitalization for newborns who were admitted to the Neonatal Intensive Care Unit (NICU)
- Inpatient hospitalization for newborns who were transferred to an acute care facility
- Inpatient hospitalization for newborns who were transferred to other health care facility
- Inpatient hospitalization for newborns who expired during the hospitalization
-
1.13a Data dictionary not attachedNo
-
Most Recent Endorsement ActivityEndorsed Perinatal and Women's Health Spring Cycle 2020Initial EndorsementLast Updated
-
StewardSteward Organization EmailSteward Organization Copyright
Measure specifications are in the Public Domain.
LOINC(R) is a registered trademark of the Regenstrief Institute.
This material contains SNOMED Clinical Terms (R) (SNOMED CT(c)) copyright 2004-2014 International Health Terminology Standards
Development Organization. All rights reserved.
Ad.7 Disclaimers: These performance measures are not clinical guidelines and do not establish a standard of medical care, and have not been tested for all potential applications. The measures and specifications are provided without warranty.
-
-
-
Risk AdjustmentRisk adjustment approachOffRisk adjustment approachOffConceptual model for risk adjustmentOffConceptual model for risk adjustmentOff
-
-
-
6.1.2 Current or Planned Use(s)6.1.3 Current Use(s)
-